LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset (ID:20245)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Barasertib | 1.11 | uM | LJP5 | 2 | D09 | 72 | hr | 513 | 1289 | 10349 | 0.1246 | 0.2367 |
MCF 10A | Barasertib | 1.11 | uM | LJP5 | 3 | D09 | 72 | hr | 513 | 1219 | 10483 | 0.1163 | 0.2198 |
MCF 10A | Barasertib | 3.33 | uM | LJP5 | 1 | D08 | 72 | hr | 513 | 1350 | 10254 | 0.1317 | 0.2508 |
MCF 10A | Barasertib | 3.33 | uM | LJP5 | 2 | D08 | 72 | hr | 513 | 1414 | 10349 | 0.1366 | 0.2634 |
MCF 10A | Barasertib | 3.33 | uM | LJP5 | 3 | D08 | 72 | hr | 513 | 1364 | 10483 | 0.1301 | 0.2517 |
MCF 10A | Barasertib | 10 | uM | LJP5 | 1 | D07 | 72 | hr | 513 | 1286 | 10254 | 0.1254 | 0.2368 |
MCF 10A | Barasertib | 10 | uM | LJP5 | 2 | D07 | 72 | hr | 513 | 1230 | 10349 | 0.1189 | 0.2234 |
MCF 10A | Barasertib | 10 | uM | LJP5 | 3 | D07 | 72 | hr | 513 | 1406 | 10483 | 0.1341 | 0.2605 |
MCF 10A | Vemurafenib | 0.04 | uM | LJP5 | 1 | C18 | 72 | hr | 513 | 10165 | 10254 | 0.9912 | 0.9959 |
MCF 10A | Vemurafenib | 0.04 | uM | LJP5 | 2 | C18 | 72 | hr | 513 | 9475 | 10349 | 0.9155 | 0.9597 |
MCF 10A | Vemurafenib | 0.04 | uM | LJP5 | 3 | C18 | 72 | hr | 513 | 10489 | 10483 | 1.0005 | 1.0002 |
MCF 10A | Vemurafenib | 0.12 | uM | LJP5 | 1 | C17 | 72 | hr | 513 | 10117 | 10254 | 0.9866 | 0.9938 |
MCF 10A | Vemurafenib | 0.12 | uM | LJP5 | 2 | C17 | 72 | hr | 513 | 10016 | 10349 | 0.9678 | 0.9849 |
MCF 10A | Vemurafenib | 0.12 | uM | LJP5 | 3 | C17 | 72 | hr | 513 | 10694 | 10483 | 1.0201 | 1.0092 |
MCF 10A | Vemurafenib | 0.37 | uM | LJP5 | 1 | C16 | 72 | hr | 513 | 9491 | 10254 | 0.9255 | 0.9645 |
MCF 10A | Vemurafenib | 0.37 | uM | LJP5 | 2 | C16 | 72 | hr | 513 | 9864 | 10349 | 0.9531 | 0.9779 |
MCF 10A | Vemurafenib | 0.37 | uM | LJP5 | 3 | C16 | 72 | hr | 513 | 10524 | 10483 | 1.0039 | 1.0018 |
MCF 10A | Vemurafenib | 1.11 | uM | LJP5 | 1 | C15 | 72 | hr | 513 | 8218 | 10254 | 0.8014 | 0.9001 |
MCF 10A | Vemurafenib | 1.11 | uM | LJP5 | 2 | C15 | 72 | hr | 513 | 8492 | 10349 | 0.8205 | 0.9108 |
MCF 10A | Vemurafenib | 1.11 | uM | LJP5 | 3 | C15 | 72 | hr | 513 | 8365 | 10483 | 0.7979 | 0.8989 |
MCF 10A | Vemurafenib | 3.33 | uM | LJP5 | 1 | C14 | 72 | hr | 513 | 3867 | 10254 | 0.3771 | 0.5958 |
MCF 10A | Vemurafenib | 3.33 | uM | LJP5 | 2 | C14 | 72 | hr | 513 | 4101 | 10349 | 0.3963 | 0.6153 |
MCF 10A | Vemurafenib | 3.33 | uM | LJP5 | 3 | C14 | 72 | hr | 513 | 5325 | 10483 | 0.5079 | 0.7117 |
MCF 10A | Vemurafenib | 10 | uM | LJP5 | 1 | C13 | 72 | hr | 513 | 1772 | 10254 | 0.1728 | 0.3321 |
MCF 10A | Vemurafenib | 10 | uM | LJP5 | 2 | C13 | 72 | hr | 513 | 1862 | 10349 | 0.1799 | 0.3463 |